I think there could well be a small group of people who benefit from rituximab either because:
- they have an as yet unidentified autoimmune disease; or
- because rituximab is effective in another way. I am not talking about placebo. We don't understand the disease mechanism in ME/CFS; therefore, rituximab could have an indirect positive effect.